尔康制药：11月14日召开董事会会议

Group 1 - The core point of the article is that Erkang Pharmaceutical held its first temporary board meeting of the sixth session on November 14, 2025, to discuss the election of the chairman of the board [1] - For the first half of 2025, Erkang Pharmaceutical's revenue composition was as follows: 79.38% from the pharmaceutical industry, 18.57% from the new energy sector, and 2.05% from other businesses [1] - As of the time of reporting, Erkang Pharmaceutical had a market capitalization of 8.1 billion yuan [1]